[go: up one dir, main page]

ES8705763A1 - Pharmaceutical compositions containing gels. - Google Patents

Pharmaceutical compositions containing gels.

Info

Publication number
ES8705763A1
ES8705763A1 ES545616A ES545616A ES8705763A1 ES 8705763 A1 ES8705763 A1 ES 8705763A1 ES 545616 A ES545616 A ES 545616A ES 545616 A ES545616 A ES 545616A ES 8705763 A1 ES8705763 A1 ES 8705763A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
compositions containing
containing gels
diagnostic
pluronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545616A
Other languages
Spanish (es)
Other versions
ES545616A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES545616A0 publication Critical patent/ES545616A0/en
Publication of ES8705763A1 publication Critical patent/ES8705763A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pharmaceutical compositions or diagnostic products containing Pluronic F-127 are disclosed which contain a therapeutic or diagnostic active quantity of the active principle and from 18 to 19% by weight of the gel-forming Pluronic F-127, as well as a method for the preparation of said products.
ES545616A 1984-07-27 1985-07-26 Pharmaceutical compositions containing gels. Expired ES8705763A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843428264 DE3428264A1 (en) 1984-07-27 1984-07-27 VALID PHARMACEUTICAL PREPARATIONS

Publications (2)

Publication Number Publication Date
ES545616A0 ES545616A0 (en) 1987-06-01
ES8705763A1 true ES8705763A1 (en) 1987-06-01

Family

ID=6242046

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545616A Expired ES8705763A1 (en) 1984-07-27 1985-07-26 Pharmaceutical compositions containing gels.

Country Status (8)

Country Link
EP (1) EP0227656A1 (en)
JP (1) JPS61502817A (en)
AU (1) AU4672385A (en)
DE (1) DE3428264A1 (en)
DK (1) DK111686A (en)
ES (1) ES8705763A1 (en)
IL (1) IL75921A0 (en)
WO (1) WO1986000813A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0386960A3 (en) * 1989-03-07 1991-10-23 American Cyanamid Company Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
JP2926749B2 (en) * 1989-04-25 1999-07-28 吉富製薬株式会社 Prostaglandin-containing liquid composition
CA2040460C (en) * 1990-05-01 1997-06-10 Tacey X. Viegas Drug delivery with thermoreversible gels
US5593683A (en) * 1990-05-01 1997-01-14 Mdv Technologies, Inc. Method of making thermoreversible polyoxyalkylene gels
US5948387A (en) * 1990-06-01 1999-09-07 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
AU6956494A (en) * 1993-06-04 1995-01-03 Warner-Lambert Company Non-alcoholic cold and sinus medication
JP2909876B2 (en) * 1994-01-24 1999-06-23 恭弘 小川 Contrast agent
US6669927B2 (en) 1998-11-12 2003-12-30 3M Innovative Properties Company Dental compositions
US6312667B1 (en) 1998-11-12 2001-11-06 3M Innovative Properties Company Methods of etching hard tissue in the oral environment
US6312666B1 (en) * 1998-11-12 2001-11-06 3M Innovative Properties Company Methods of whitening teeth
US6620405B2 (en) * 2001-11-01 2003-09-16 3M Innovative Properties Company Delivery of hydrogel compositions as a fine mist
RU2741710C1 (en) * 2018-07-12 2021-01-28 Елена Валентиновна Аршинцева Thermal method for sterilization of liquid medicinal agents containing poloxamer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867521A (en) * 1970-08-26 1975-02-18 Scherer Corp R P Method for absorption of drugs
US3852210A (en) * 1972-08-11 1974-12-03 Flow Pharma Inc Stable liquid detergent concentrates containing active oxygen
CA1051776A (en) * 1974-08-09 1979-04-03 Murray W. Winicov Poloxamer-iodine gel
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
CA1072413A (en) * 1976-07-13 1980-02-26 West Laboratories Poloxamer gel systems with gelling temperatures higher than room temperature
US4365516A (en) * 1978-01-06 1982-12-28 Rockwell International Corporation Ultrasonic couplant gel compositions and method for employing same
DE2966768D1 (en) * 1978-12-19 1984-04-12 Byk Gulden Lomberg Chem Fab Solutions of x-ray contrast agents
SE431821B (en) * 1979-01-29 1984-03-05 Perstorp Ab STORAGE STABLE, PROSTAGLANDIN-CONTAINING MEDICAL PREPARATION

Also Published As

Publication number Publication date
ES545616A0 (en) 1987-06-01
EP0227656A1 (en) 1987-07-08
WO1986000813A1 (en) 1986-02-13
JPS61502817A (en) 1986-12-04
DE3428264A1 (en) 1986-03-06
IL75921A0 (en) 1985-12-31
DK111686D0 (en) 1986-03-11
DK111686A (en) 1986-03-11
AU4672385A (en) 1986-02-25

Similar Documents

Publication Publication Date Title
IT8122859A0 (en) DERIVATIVES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THEIR PREPARATION.
NO170126C (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS IN THE FORM OF SUSPENSIONS CONTAINING SUCRALPHAT
MY101791A (en) New benzimidazole derivatives
ES8600060A1 (en) Galenic form for the administration by inhalation of calcium antagonists.
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
IL81002A (en) 3,4-diphenyl-pyrazoline-1-carboxamide derivatives,processes for the preparation thereof and insecticidal and acaricidal compositions containing the same
IL58697A0 (en) Analgesic pharmaceutical compositions in the form of effervescent powders comprising metoclopramide
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
ES8705763A1 (en) Pharmaceutical compositions containing gels.
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
DE2963990D1 (en) Analgesic tablet and process for its preparation
IT8025159A0 (en) MEDICINAL PREPARATION WITH CYTOSTATIC ACTION, AS WELL AS DERIVATIVES OF ISOCYANURIC ACID AND PROCEDURE FOR THEIR PREPARATION.
HUT41750A (en) Process for preparing 2-hydroxy-4h-3,1-benzazin-4-one derivatives, pharmaceutical compositions containing thereof as active ingredients and intermediers thereof
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT56556A (en) Process for producing new piperazinecarboxamides containing phenoxyalkyl or thiophenoxyalkyl side chain, as well as pharmaceutical compositions comprising such compounds as active ingredient
ZA848141B (en) New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
ES8800217A1 (en) Use of 4-(isoxazolyl)-thiazole-2-oxamic acid derivatives.
HUT41965A (en) Insecticide compositions containing s,s-di/terc-alkyl/-thiophosphonate derivatives as active agents and process for producing the active agents
DE3273193D1 (en) Cream base
ES8504166A1 (en) 6,11-Dihydro-11,-oxo-dibenz(b,e)-oxepin derivatives, methods for their preparation, pharmaceutical compositions containing the same and their use as medicaments.
IL58576A0 (en) 2-substituted and 2,6 disubstituted penem compounds their preparation and pharmaceutical compositions containing them
FR2567402B1 (en) NOVEL PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING DIHYDROXY-1,8 PHENYL-10 ANTHRONE-9 AS ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE ACTIVE INGREDIENT
ES8504665A1 (en) P-Acylaminophenol derivatives with a therapeutical effect, process for their preparation, and compositions with a therapeutical effect containing these derivatives as pharmacologically active ingredients.